Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients.

Cancer Chemotherapy and Pharmacology
Nuala A HelsbyDavid Porter

Abstract

Genetic variation in the activation of the prodrug cyclophosphamide (CP) by cytochrome P450 (CYP) enzymes has been shown to influence outcomes. However, CYP are also subject to phenoconversion due to either the effects of comedications or cancer associated down-regulation of expression. The aim of this study was to assess the relationship between CP bioactivation with CYP2B6 and CYP2C19 genotype, as well as CYP2C19 phenotype, in breast cancer patients. CP and the active metabolite levels were assessed in breast cancer patients (n = 34) at cycle 1 and cycle 3 of treatment. Patients were genotyped for a series of SNP known to affect CYP2B6 and CYP2C19 function. The activity of CYP2C19 was also assessed using a probe drug. We found a significant linear gene-dose relationship with CYP2B6 coding SNP and formation of 4-hydroxycyclophosphamide. A possible association with CYP2C19 null genotype at cycle 1 was obscured at cycle 3 due to the substantial intra-individual change in CP bioactivation on subsequent dosing. Comedications may be the cause for this inter-occasion variation in bioactivation of cyclophosphamide and the ensuing phenoconversion may account for the conflicting reports in the literature about the relationship between ...Continue Reading

References

May 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J T SlatteryF R Appelbaum
May 3, 2000·British Journal of Clinical Pharmacology·M L WilliamsI W Wainer
May 15, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M A BateyA V Boddy
Jun 18, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Celeste LindleyEdward L LeCluyse
Aug 24, 2005·The Pharmacogenomics Journal·R TimmI Cascorbi
Sep 27, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Hanjing XieMoustapha Hassan
Oct 20, 2005·Clinical Pharmacokinetics·Milly E de JongeJos H Beijnen
Jun 20, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Alison E Aitken, Edward T Morgan
Oct 16, 2008·British Journal of Cancer·N A HelsbyM Findlay
Dec 24, 2010·British Journal of Clinical Pharmacology·Nuala A HelsbyMalcolm D Tingle
Jan 17, 2012·Cancer Chemotherapy and Pharmacology·Christine M WalkoE Claire Dees
Oct 23, 2012·Frontiers in Genetics·Nuala Ann Helsby, Kathryn Elisa Burns
Apr 29, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Sonam TulsyanBalraj Mittal
Nov 29, 2015·Cancer Chemotherapy and Pharmacology·K E BurnsN A Helsby
Jan 17, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gareth J VealAlan V Boddy
Oct 7, 2016·Acta Pharmaceutica Sinica. B·William D HedrichHongbing Wang
Jan 27, 2019·Mutation Research. Genetic Toxicology and Environmental Mutagenesis·Yuki KishinoKazuhiko Mori
Feb 23, 2020·International Journal of Molecular Sciences·Marianne K O GrantBeshay N Zordoky
Sep 11, 2020·Journal of Clinical Medicine·Sylvia D KlompJesse J Swen
Dec 21, 2020·Clinical Pharmacology and Therapeutics·Camille LenoirCaroline Flora Samer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.